top of page
Rinnit logo – modern health products and health news

Rosai-Dorfman Disease: Symptoms, Causes, and Management

Oct 7
6 min read

Updated: 3 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer: What is Rosai-Dorfman disease?

Rosai-Dorfman disease (RDD) is a rare, benign overgrowth of histiocytes, a type of white blood cell. The most common sign is painless swelling of the lymph nodes in the neck, though it can also involve the skin, sinuses or brain. Diagnosis usually requires a tissue biopsy, and management ranges from observation to surgery, corticosteroids or targeted therapies. [1]

Rosai-Dorfman Disease Overview: Histiocyte overgrowth and lymphatic system impact. – rinnit.com
Rosai-Dorfman disease involves an overgrowth of histiocytes, most often causing painless swelling of lymph nodes in the neck.

What the research says

  • Gene mutations are found in a large share of cases. MAPK/ERK pathway mutations are present in 30% to 50% of RDD cases, and next-generation sequencing is recommended for patients who need treatment so that targeted therapy can be considered (Ravindran & Rech, Am J Clin Pathol, 2023). [2]

  • Most cases can be watched or treated locally. More than 1,000 reports on RDD have been published, yet the first consensus recommendations (2018) state that in most cases RDD can be observed or treated with local therapies, while some patients with refractory or multifocal disease experience serious illness (Abla et al., Blood, 2018). [3]

  • Disease outside the lymph nodes is easy to miss. In a systematic review of 69 cases of RDD of the spine, 39.1% had lesions in more than one organ, and among 47 patients who first had spine-related symptoms, 93.6% were misdiagnosed before surgery. About 19.5% of cases had a recurrence or progression (Hu et al., Syst Rev, 2021). [4]

What is Rosai-Dorfman disease?

Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is characterized by an abnormal accumulation of histiocytes. These cells are essential components of the immune system that normally fight infections, but their excessive growth leads to inflammation and tissue damage. While RDD is benign and not a form of cancer, the resulting growths can interfere with organ function depending on their location. [1]

The condition is relatively rare and most frequently diagnosed in children, teenagers, and young adults, with most diagnoses occurring at about age 20. However, RDD can affect individuals of any age. Experts categorize the disease into two primary forms based on where the histiocytes collect in the body. [1]

Primary Types of Rosai-Dorfman Disease

The classification of RDD is determined by the involvement of lymph nodes versus other tissues. Approximately 40% of individuals with RDD experience extranodal involvement in addition to swollen lymph nodes. [1]

Type

Description

Common Locations

Classic (Nodal) RDD

The most frequent form, primarily affecting the lymphatic system.

Neck, armpits, chest, and groin lymph nodes.

Extranodal RDD

Histiocytes accumulate in tissues outside the lymph nodes.

Skin (cutaneous RDD), sinuses, eyes, brain, and bone.

RDD Comparison: Classic nodal vs. extranodal forms affecting skin, sinuses, and organs. – rinnit.com
Classic (nodal) RDD affects the lymph nodes, while extranodal RDD involves the skin, sinuses, and other organs.

What are the symptoms and warning signs of Rosai-Dorfman disease?

Symptoms of Rosai-Dorfman disease vary significantly based on the affected area. For many, the only noticeable sign is painless, swollen lumps on both sides of the neck. When the condition involves organs beyond the lymph nodes, symptoms become site-specific. [1]

Nodal and Systemic Symptoms

In addition to visible swelling, classic RDD may present with systemic signs of inflammation. These symptoms often mimic other common illnesses, making professional diagnosis essential. [1]

  • Persistent fatigue and low energy. [1]

  • Unexplained fever or night sweats. [1]

  • Pale skin and unintended weight loss. [1]

Extranodal Symptoms by Location

When RDD affects specific organs or the skin, the symptoms reflect the disruption of those tissues. Cutaneous RDD (CRDD) typically presents as slow-growing growths that may be yellow, purple, red, or brown. Sinus involvement often leads to chronic stuffiness, while brain involvement may trigger seizures or double vision if the eyes are affected. [1]

What causes Rosai-Dorfman disease, and who is at risk?

The precise cause of Rosai-Dorfman disease remains unknown to medical researchers. However, studies have found common gene mutations in about 3 to 5 out of 10 people with RDD (30% to 50%), which can cause cells to grow out of control. Knowing about these mutations has helped experts develop new treatments for RDD. [1] [2]

Many people with RDD also have other conditions. There may be a connection between these conditions and RDD, but more research is needed to know for sure. Associated conditions include: [1]

  • Autoimmune disorders: lupus, juvenile idiopathic arthritis, and autoimmune hemolytic anemia. [1]

  • Viral infections: Epstein-Barr virus (EBV), herpes, cytomegalovirus, and HIV. [1]

  • Cancers: Hodgkin and non-Hodgkin lymphoma. [1]

How is Rosai-Dorfman disease diagnosed and managed?

Diagnosing RDD requires a comprehensive evaluation to rule out other causes of lymphadenopathy. Providers typically use a combination of physical exams, blood tests to check for atypical cells, and imaging procedures to locate internal histiocyte clusters. A tissue biopsy is often necessary to confirm the diagnosis. [1]

Treatment Options

Treatment is highly individualized. Patients without symptoms may only require regular monitoring to ensure the condition does not progress. For those requiring intervention, the strategy depends on whether the disease is local or widespread. [1]

Treatment Category

Description

Common Examples

Local Therapy

Used for RDD confined to a single area.

Surgery, radiation, or topical steroid creams.

Targeted Therapy

Medicines designed to treat specific gene mutations.

MEK inhibitors (cobimetinib, trametinib).

Systemic Therapy

Used for widespread disease or inflammation.

Corticosteroids (prednisone), immunosuppressants.

Chemotherapy

Destroys fast-dividing abnormal histiocytes.

Low-dose methotrexate, cladribine.

Rosai-Dorfman Disease Management Roadmap: From monitoring and diagnosis to local and systemic treatments. – rinnit.com
RDD care moves from monitoring and diagnosis to local treatment and, when needed, systemic therapy.

What is the outlook for Rosai-Dorfman disease?

For the majority of individuals, Rosai-Dorfman disease is not life-threatening and does not significantly impact life expectancy. In some cases, the condition may undergo spontaneous remission, disappearing on its own within months or years. The prognosis is generally better when fewer lymph nodes are involved. Newer targeted therapies have further improved outcomes for those with more complex cases. [1]

Conclusion

Rosai-Dorfman disease is a rare but manageable condition. Because it affects every individual differently, a personalized care plan developed by a multidisciplinary team is crucial for optimal results. If you notice unusual, persistent swelling in your neck or skin growths, consult a healthcare professional for an evaluation.

What are the next steps for Rosai-Dorfman disease?

Ready to learn more about managing rare conditions? Explore our library of resources or speak with a specialist today.

Frequently Asked Questions

No, Rosai-Dorfman disease is considered a benign, noncancerous condition. While it involves the overgrowth of white blood cells, it does not spread in the same way as malignant tumors. [1]

The condition primarily affects children and young adults, with most diagnoses occurring around age 20. However, it can occur at any age. [1]

Yes, spontaneous remission is possible, where the condition disappears without treatment. The timeline for this is unpredictable and can range from months to years. [1]

Cutaneous Rosai-Dorfman disease is a type of RDD that affects the skin. It typically presents as slow-growing, discolored bumps or growths. [1]

Diagnosis usually involves a physical exam, blood tests, imaging (like CT or MRI), and a biopsy of the affected tissue to confirm the presence of excess histiocytes. [1]

MEK inhibitors are targeted therapy drugs used to treat RDD patients who have specific gene mutations. They help stop the signals that cause cells to grow uncontrollably. [1]

In most cases, RDD does not impact life expectancy. It is generally not life-threatening, though it can cause serious issues if it impacts major organ function. [1]

Yes, the condition can sometimes recur after a period of remission. Regular monitoring with a healthcare provider is recommended. [1]

Sinus involvement often causes symptoms similar to a chronic cold, such as persistent stuffiness or congestion. [1]

While some cases are associated with inherited syndromes like H syndrome, most cases of RDD do not appear to be directly inherited from parents.

Because RDD can affect many organs, treatment often involves a team including hematologists, oncologists, dermatologists, and other specialists depending on the affected areas.

No, swollen lymph nodes are much more commonly caused by infections like the cold or flu. RDD is a very rare cause of lymphadenopathy.

Extranodal refers to disease that occurs outside of the lymph nodes, such as in the skin, bones, or organs. [1]

Yes, corticosteroids like prednisone are commonly used to reduce inflammation and calm the immune system in RDD patients. [1]

While there isn’t a single “cure,” many patients achieve long-term remission through treatment or spontaneous recovery.

References

  1. Cleveland Clinic. Rosai-Dorfman disease. Cleveland Clinic. March 24, 2026. https://my.clevelandclinic.org/health/diseases/24145-rosai-dorfman-disease

  2. Ravindran A, Rech KL. How I diagnose Rosai-Dorfman disease. Am J Clin Pathol. 2023;160(1):1-10. PMID 37167084. https://doi.org/10.1093/ajcp/aqad047

  3. Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131(26):2877-2890. PMID 29720485. https://doi.org/10.1182/blood-2018-03-839753

  4. Hu PP, Wei F, Liu XG, et al. Diagnosis and treatment of Rosai-Dorfman disease of the spine: a systematic literature review. Syst Rev. 2021;10(1):31. PMID 33461611. https://doi.org/10.1186/s13643-021-01581-0

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Comments


bottom of page